Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Weight loss drug gets US nod to treat sleep apnea
FDA approves first medication for obstructive sleep apnea, which also promotes weight loss
The FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep expert Dr. Wendy Troxel discusses the impact of the new development.
F.D.A. Approves Weight Loss Drug to Treat Obstructive Sleep Apnea
Zepbound is the first prescription drug approved specifically to treat the common condition. The Food and Drug Administration on Friday approved the weight loss drug Zepbound to treat obstructive sleep apnea. It is the first prescription medication approved to treat the common sleep disorder.
Zepbound Weight Loss Medication Approved by FDA to Treat Sleep Apnea
The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as tirzepatide, to help people treat obstructive sleep apnea.
Tirzepatide Gets FDA Approval for Sleep Apnea in Adults With Obesity
The nod, just months after topline results from SURMOUNT-OSA came out, makes it the first drug approved for this indication.
Obesity Drug Zepbound Approved for Obstructive Sleep Apnea
The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to severe OSA in people with obesity.
FDA approves Zepbound for sleep apnea in patients with obesity
The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).
Weight Loss Drug Tirzepatide Now Approved for Sleep Apnea in Adults With Obesity
The approval was based on the results of the SURMOUNT-OSA trial, which found patients had fewer breathing disruptions.
Eli Lilly Gets FDA Approval for Zepbound for Certain Sleep Apnea Patients
Eli Lilly said the FDA approved Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity, the first and only prescription medicine for those suffering from this condition.
Weight loss drug Zepbound gets US FDA nod to treat sleep apnea; India launch expected in 2025
In a groundbreaking move, the US Food and Drug Administration (FDA) has approved the anti-diabetic drug Zepbound, also known as Tirzepatide, for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity.
5d
on MSN
The First Sleep Apnea Drug Is Here
In the trial that Lilly, the drug's manufacturer, submitted in April to the FDA, scientists reported that the drug helped ...
3d
on MSN
Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound
Shares of ResMed and Inspire Medical Systems fell after the FDA approved Eli Lilly's weight-loss drug Zepbound to treat ...
USA Today
5d
The popular weight-loss drug Zepbound can now be used to treat sleep apnea
Sleep
apnea
can significantly increase health risks ... The drug's active ingredient,
tirzepatide
, is marketed as Zepbound for weight loss and Mounjaro as a diabetes treatment.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
'Baby Driver' actor dies
Man dies after saving family
4 found dead in NH home
Christmas Eve attack arrest
Corrections officer dies
Body found in wheel well
Pakistani airstrikes on AFG
Escaped murderer captured
HEARTS Act signed into law
Former Eagles LB dies at 79
Vows more weapons to UKR
Official national bird of US
Finland probes oil tanker
Phoenix airport shooting
Hit by cyberattack
Ambassador to Panama
Teases 'Happy Gilmore 2'
Holiday retail sales rise
Taxi hits pedestrians in NYC
Breaks QB rushing record
Jackpot surges past $1B
Mortgage rate climbs
Russia arrests four suspects
India's former PM dies
Suriname ex-president dies
Taiwan blocks $950M deal
ISR strike kills journalists
Kazakhstan plane crash
Bird flu at Wash. sanctuary
Weekly jobless claims fall
Pet food recalled
Related topics
Zepbound
Food and Drug Administration
Eli Lilly
Feedback